02389 BJ HEALTH
- 0.071
- +0.001+1.43%
BJ HEALTH News
Zhitong Hong Kong Shareholders' Rights Disclosure | May 15
Disclosure of Hong Kong Stock Shareholders' Rights | May 15
Beijing Health (02389.HK) received an OTC share increase of 1,062 million shares worth HK$69.44,300 from China Vista Capital Limited
On May 14, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 14, China Vista Capital Limited increased its OTC share holdings of $Beijing Health (02389.HK) $1,062 million at an average price of HK$0.065 per share on May 14, worth approximately HK$69.44,300. After the increase in holdings, China Vista Capital Limited's latest shareholding was 1,062 million shares, and the good position ratio increased from 0.00% to 17.53%. This transaction involves other related parties: Chi
Beijing Financial Investment Holdings Limited sold 605 million shares of Beijing Health (02389.HK) common shares worth approximately HK$393.384 million off the market
On May 14, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 14, Beijing Financial Investment Holdings Limited sold $605 million shares of $Beijing Health (02389.HK) $605 million on May 14 at an average price of HK$0.065 per share, worth approximately HK$39.384 million. After the sale, the latest number of shares held by Beijing Financial Investment Holdings Limited was 0 shares, which is a good position ratio
北京健康：年報2023
Beijing Health (02389) Announces 2023 Results Loss attributable to parent company owners of HK$61.882 million narrowed 36.66% year-on-year
According to the Zhitong Finance App, Beijing Health (02389) announced its 2023 results, with revenue of about HK$140 million, a year-on-year decrease of 15.7%; parent company owners should have accounted for a loss of HK$61.882 million, a year-on-year decrease of 36.66%; and a loss of 1.01 HK cents per share. According to the announcement, the decline in revenue was mainly due to an 18.5% decrease in sales revenue of medical products to HK$128.6 million. The main customer source for the Healthcare Products Division comes mostly from tender orders from enterprises and institutions. The cycle from winning the bid to delivery of the product is about half a year to one year. Due to the second half of 2022, China is still affected by the COVID-19 pandemic
BJ HEALTH: ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Beijing Health (02389.HK) plans to hold a board meeting on March 28 to approve annual results
Gelonghui, March 1, 丨 Beijing Health (02389.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the Group's annual results for the year ended December 31, 2023, pay a final dividend (if any), and deal with other matters.
Beijing Health (02389): Hu Xiangqi Resigns as Executive Director
Zhitong Finance App News, Beijing Health (02389) issued an announcement. Hu Xiangqi has proposed the resignation of the company's executive director, effective February 29, 2024; Zhao Gang has proposed to resign as an independent non-executive director of the company, effective February 29, 2024; and Kang Shixue has proposed to resign as an independent non-executive director of the company, effective February 29, 2024. The reasons are all due to the need to invest more time in other personal matters.
Huatai Securities: The silver economy may spawn a series of investment opportunities from the capital side, demand side, and supply side
As China's aging deepens, the introduction of the first banking economic policy may spawn a series of investment opportunities from the demand side, supply side, and capital side.
Beijing Health Buys Carnarvon Street Promissory Notes
Beijing Health (Holdings) (HKG:2389) purchased promissory notes worth about CA$7.3 million, issued by 813 Carnarvon Street Developments Limited Partnership, this month. The notes carry a 10% interest
Beijing Health (02389.HK) purchases acceptance notes
Gelonghui, January 31, 丨 Beijing Health (02389.HK) announced that on January 31, 2024, the company used its internal resources to purchase acceptance notes (“acceptance note I”) issued by the issuer with an amount of 4.28 million Canadian dollars. Additionally, on January 2, 2024, the Company used its internal resources to purchase acceptance notes (“Acceptance Notes II”) issued by the issuer in the amount of 3 million Canadian dollars. Promissory Note I and Promissory Note I issuer 813 Carnarvon Street Developments Limited Partnership is a company in
Ministry of Civil Affairs: Increase the supply of old-age services and cultivate new forms of old-age services
Li Yongxin, head of the Department of Elderly Care Services of the Ministry of Civil Affairs, said at a press conference that in the next step, the Ministry of Civil Affairs will increase the supply of old-age services. Develop meal aid services for the elderly, guide all regions to implement action plans to actively develop meal aid services for the elderly, innovate organizational forms, service models and operating mechanisms for the elderly, and continuously expand the scope and improve quality and efficiency on a sustainable basis.
Beijing Health Raises Stake in Beijing Lugang International Logistics for 48 Million Yuan
Beijing Health (Holdings) (HKG:2389), through subsidiary Beijing Zhongcheng-Hulian Investment Consulting, agreed to acquire 12.7% of Beijing Lugang International Logistics for a consideration of 48 mi
Beijing Health (02389) will cooperate with the Cultural Tourism Group to renovate the ancient canal cultural and creative building
Beijing Health (02389) announced that on November 10, 2023, the group and Liangxi Cultural Tourism Development in Wuxi City...
Luo Xin Pharmaceutical (002793.SZ): Plans to transfer part of the shares in Beijing Health and increase its capital
Gelonghui, October 13丨Luo Xin Pharmaceutical (002793.SZ) announced that the company holds 51% of the shares of the holding subsidiary Luo Xin Health Technology Development (Beijing) Co., Ltd. (“Beijing Health” and “target company” for short) (corresponding to the registered capital of the target company of 116.23 million yuan). Another shareholder of Beijing Health, Chengdu Deyi Xinhua Equity Investment Partnership (Limited Partnership) (“Chengdu Deyi” for short) holds 49% of Beijing Health's shares (corresponding to the registered capital of the target company is 111.67 million yuan, the actual payment amount is RMB 67.37 million, and the actual payment ratio is 36.69%). Chengdu Deyi plans to play
BJ HEALTH: INTERIM REPORT 2023
BJ HEALTH: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
Beijing Health (02389) granted 21 million yuan in short-term loan financing
Beijing Health (02389) issued an announcement. On August 30, 2023, the lender (a non-wholly owned subsidiary of the company, North...
Beijing Health (02389) announced its interim results, loss of HK$1,832 million decreased by 48% year-on-year
Beijing Health (02389) announced the results for the first half of 2023. The company achieved a year-on-year decrease of 15.0% in revenue to 7...
BJ HEALTH: ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE PERIOD ENDED 30 JUNE 2023
Analysis
Price Target
No Data
